Good morning, Boston. Here are the five things you need to know in Boston business news to start your workday, and some good news (maybe) about the price of eggs, if not the price of groceries overall.
What's next for Vertex?
The company best-known for its cystic fibrosis drugs is banking its future on a variety of other disease area, including a CRISPR-based gene therapy for sickle-cell disease and transfusion-dependent beta thalassemia, reports Rowan Walrath.
Big Pharma looks to go shopping
The…
